Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
Titel:
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
Auteur:
Ferrari, S. Adachi, J. D. Lippuner, K. Zapalowski, C. Miller, P. D. Reginster, J.-Y. Törring, O. Kendler, D. L. Daizadeh, N. S. Wang, A. O’Malley, C. D. Wagman, R. B. Libanati, C. Lewiecki, E. M.